These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3753678)
1. Detection of Müllerian inhibiting substance in biological samples by a solid phase sandwich radioimmunoassay. Necklaws EC; LaQuaglia MP; MacLaughlin D; Hudson P; Mudgett-Hunter M; Donahoe PK Endocrinology; 1986 Feb; 118(2):791-6. PubMed ID: 3753678 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody to Mullerian inhibiting substance. Mudgett-Hunter M; Budzik GP; Sullivan M; Donahoe PK J Immunol; 1982 Mar; 128(3):1327-33. PubMed ID: 6895760 [TBL] [Abstract][Full Text] [Related]
3. Production of monoclonal antibodies for affinity purification of bovine mullerian inhibiting substance activity. Shima H; Donahoe PK; Budzik GP; Kamagata S; Hudson P; Mudgett-Hunter M Hybridoma; 1984; 3(3):201-14. PubMed ID: 6548727 [TBL] [Abstract][Full Text] [Related]
4. Antibody against avian müllerian inhibiting substance (MIS) recognizes MIS on rat müllerian duct and human tumor cells. Wang JJ; Teng CS Proc Natl Sci Counc Repub China B; 1989 Oct; 13(4):267-75. PubMed ID: 2484046 [TBL] [Abstract][Full Text] [Related]
5. Serum levels of müllerian inhibiting substance in boys from birth to 18 years, as determined by enzyme immunoassay. Baker ML; Metcalfe SA; Hutson JM J Clin Endocrinol Metab; 1990 Jan; 70(1):11-5. PubMed ID: 2403569 [TBL] [Abstract][Full Text] [Related]
6. An immunoassay to detect human müllerian inhibiting substance in males and females during normal development. Hudson PL; Dougas I; Donahoe PK; Cate RL; Epstein J; Pepinsky RB; MacLaughlin DT J Clin Endocrinol Metab; 1990 Jan; 70(1):16-22. PubMed ID: 2294129 [TBL] [Abstract][Full Text] [Related]
7. Human recombinant mullerian inhibiting substance inhibition of rat oocyte meiosis is reversed by epidermal growth factor in vitro. Ueno S; Manganaro TF; Donahoe PK Endocrinology; 1988 Sep; 123(3):1652-9. PubMed ID: 2456917 [TBL] [Abstract][Full Text] [Related]
8. Cellular localization of müllerian inhibiting substance in the developing rat ovary. Ueno S; Takahashi M; Manganaro TF; Ragin RC; Donahoe PK Endocrinology; 1989 Feb; 124(2):1000-6. PubMed ID: 2643506 [TBL] [Abstract][Full Text] [Related]
9. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS. Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763 [TBL] [Abstract][Full Text] [Related]
10. Mullerian-inhibiting substance secretion is delayed in XX sex-reversed dog embryos. Meyers-Wallen VN; MacLaughlin D; Palmer V; Donahoe PK Mol Reprod Dev; 1994 Sep; 39(1):1-7. PubMed ID: 7999353 [TBL] [Abstract][Full Text] [Related]
14. A monoclonal antibody against bovine anti-Müllerian hormone. Vigier B; Picard JY; Josso N Endocrinology; 1982 Jan; 110(1):131-7. PubMed ID: 6895620 [TBL] [Abstract][Full Text] [Related]
15. Anti-idiotypic antibodies to a monoclonal antibody raised against anti-müllerian hormone exhibit anti-müllerian biological activity. Lefèvre G; Tran D; Hoebeke J; Josso N Mol Cell Endocrinol; 1989 Mar; 62(1):125-33. PubMed ID: 2787251 [TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical localization of Mullerian inhibiting substance in the rough endoplasmic reticulum and Golgi apparatus in Sertoli cells of the neonatal calf testis using a monoclonal antibody. Hayashi M; Shima H; Hayashi K; Trelstad RL; Donahoe PK J Histochem Cytochem; 1984 Jun; 32(6):649-54. PubMed ID: 6373916 [TBL] [Abstract][Full Text] [Related]
17. Highly purified müllerian inhibiting substance inhibits human ovarian cancer in vivo. Stephen AE; Pearsall LA; Christian BP; Donahoe PK; Vacanti JP; MacLaughlin DT Clin Cancer Res; 2002 Aug; 8(8):2640-6. PubMed ID: 12171896 [TBL] [Abstract][Full Text] [Related]